Summit stocks fell hard recently... in response to "disappointing clinical trial results". Ivonescimab failed to produce a statistically significant... Overal Survival benefit in the phase 3 Harmoni trial.

The stock dropped to $21.80 at 10:35 am... took 65 minutes to recover to $24.55.
Previous high $36.74 on April 24th/2025.

Love to have these numbers...both high and low.